RA13 Public National TV, Italy: Professor Davide Bona on the RefluxStop™ procedure for acid reflux

Another Major European Center of Excellence in Italy Offers the RefluxStop™ procedure.
The two RefluxStop™ procedures were successfully performed by Professor Davide Bona, Director of the General Surgery Operative Unit at I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio in Milan, Italy and Associate Professor of General Surgery, University of Milan, joined by Professor Luigi Bonavina, Head of University General Surgery Unit and Esophagus Center at Policlinico San Donato in Milan, Italy and Full Professor of General Surgery, University of Milan.
Professor Luigi Bonavina, President of the European Foregut Society (EFS) and of the Italian Association of ESophageal Research (AIRES), who attended and observed the procedures performed, said, “In Italy, about 20% of the population suffer from gastroesophageal reflux disease, and very few of these patients are aware that there are surgical treatments available to treat reflux. Most are placed and kept on long-term medication use, although only a small percentage report satisfactory symptom relief. The use of medication to manage GERD is intended to be a short-term solution for those well managed by it. Medication treats only the symptoms of GERD but does not solve the anatomical defect of the body’s natural anti-reflux barrier. It is important for us surgeons to be able to offer the available treatment options to guarantee the best results. The continuing technological advancements in treating this disease are exciting, and the initial results with the RefluxStop procedure are certainly encouraging.”
IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milan, as part of the San Donato Group hospital group that was recognized within the category 'World's Best Hospitals 2022' by Newsweek magazine in collaboration with the online research platform Statista. Over 2,200 hospitals from 27 countries around the world were involved.
“This innovative minimally invasive surgical procedure allows for the treatment of gastroesophageal reflux by restoring the normal physiology of the esophagogastric junction. It is a technique that, does not encircle and restrict the food passageway and, thus, avoids the onset of some of the most common side effects of current anti-reflux surgical procedures, such as swallowing difficulties (dysphagia), gas bloating (abdominal distension), inability to belch and vomit. The new IRCCS Galeazzi - Sant'Ambrogio Hospital in Milan is synonymous with technological innovation and guarantees our patients the possibility to receive treatment with the latest generation of instruments and devices. This intervention broadens the solutions available to the surgeon to offer the best treatment option for each patient. We are happy to have started and spearheaded a new path in the field of anti-reflux surgery which will certainly see the involvement of other centres in Italy in the coming months,” said Professor Davide Bona.

[@ritacosiminadileone3859]

❤

[@matt78934]

Beh a leggere la community estera fatta da, 750 membri questa procedura non ha migliorato più di tanto la qualità di vita dei pz. Post operatorio non semplicissimo.

[@MUDHD]

Puoi dire dove hai letto questo? Perché da quello che si trova in giro, quello che dicono i chirurghi e via dicendo, invece dicono esattamente l opposto!

[@giovlalli]

Ciao Matt
Puoi dirmi qualcosa su quello che hai scritto, xké devo prendere una decisione se fare o meno questo tipo di intervento.
Grazie

[@MUDHD]

@@giovlalli fossi in te, cercherei risposte altrove!! Io penso di essere in una situazione simile alla tua, e tra due giorni ho visita dal chirurgo. Comunque Implantica( azienda produttrice del dispositivo) ha da poco messo online gli ultimi report (dei 4anni) che sono positivi. Ad ogni modo, ripeto, non credo che sia valida la scelta di “seguire” suggerimenti da un commento qui su RUclips…lo dico per te/noi